08/19/2024
7:16 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
6:52 PM | Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
7:58 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
8:46 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:41 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:42 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/27/2024
8:42 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
8:45 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:03 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:28 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:39 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
8:44 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:17 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:37 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
8:45 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:53 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:03 PM | Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:39 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2024
5:48 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
8:36 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
8:53 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | Madrigal Pharmaceuticals (Filer)
| Form S-3ASR | |
05/07/2024
8:00 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:06 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:49 PM | Madrigal Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024
7:50 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
7:53 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
7:50 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
7:50 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:41 PM | Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:44 PM | BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:47 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:22 PM | Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:21 PM | BAKER BROS. ADVISORS LP (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:28 PM | BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/21/2024
3:30 PM | Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2024
3:11 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:10 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:01 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
5:32 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Why billionaires are wiring money to abandoned towns (Ad) A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.  Click here for my exclusive video |
02/14/2024
1:50 PM | ARMISTICE CAPITAL, LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:21 AM | Avoro Capital Advisors LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
4:55 PM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
5:04 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:50 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
4:54 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
10:13 AM | Madrigal Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
12:52 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
12:39 PM | Howarth Alex G. (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
12:45 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
12:46 PM | Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
12:47 PM | FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
12:45 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:30 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
5:09 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
5:10 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:30 PM | Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:25 PM | CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:30 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:30 PM | Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:02 PM | Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:15 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:24 PM | BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/15/2023
4:12 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
4:13 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
3:39 PM | Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
| Form SC 13G | |
11/06/2023
7:31 AM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:10 AM | Madrigal Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
12:05 PM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/05/2023
3:36 PM | BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/05/2023
3:27 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:15 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:10 PM | Madrigal Pharmaceuticals (Filer)
| Form 424B5 | |
09/28/2023
3:01 PM | Madrigal Pharmaceuticals (Filer)
| Form 424B5 | |
09/25/2023
3:02 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:31 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
3:35 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
3:41 PM | Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:25 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
3:30 PM | Madrigal Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
3:31 PM | Madrigal Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/08/2023
3:36 PM | JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
| Form SC 13G | |
